Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain

Clinical Chemistry

Volumn 43, Issue 2, 1997, Pages 326-332

  Wu, Alan H B ^a   Clive, Jonathan M ^b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

creatine kinase; Diagnosis Related Group; isoenzymes; laboratory management; outcomes analysis; random access analysis; turnaround times

Indexed keywords

CREATINE KINASE MB;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; DIAGNOSIS RELATED GROUP; HEALTH CARE POLICY; HOSPITAL CHARGE; HOSPITAL COST; HOSPITAL LABORATORY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICARE; OUTCOMES RESEARCH; THORAX PAIN; UNITED STATES;

ANGINA;

EID: 0031034214     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.2.326     Document Type: Article

References (21)

1. Department of Health and Human Services, Health Care Financing Administration. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 1996 rates. Fed Reg 1995;60:45893-903.
2. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986;105:221-33.
3. Flapan AD. Management of patients after their first myocardial infarction. Br Med J 1994;309:1129-34.
4. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol 1995;26: 66-72.
5. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Morgan JH, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1995;26: 668-74.
6. Secchiero S, Altinier S, Zaninotto M, Lachin M, Plebani M. Evaluation of a new automated system for the determination of CK-MB isoforms. J Clin Lab Anal 1995;9:359-65.
7. Gibier WB, Gibier CD, Weinshenker E, Abbottsmith C, Hedges JR, Barsan WG, et al. Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med 1987;16:851-6.
8. Wu AHB, Feng YJ, Contois JH, Pervaiz S. Comparison of myoglobin, creatine kinase-MB and cardiac troponin I for diagnosis of acute myocardial infarction. Ann Clin Lab Sci 1996;26:291-300.
9. Wu AHB. Cardiac troponin T: biochemical, analytical, and clinical aspects. J Clin Immunoassay 1994;17:45-8.
10. DRG guidebook. Reston, VA: St. Anthony Publishing, 1995:55-62.
11. Design, development of the All Patient Refined Diagnosis Related Groups, Ver. 12.0. Wallingford, CT: 3 M Health Information Systems, 1995:27pp.
12. Directory of US hospitals. Chicago: American Hospital Association, 1994:A216-26.
13. Hospital statistics. Chicago: American Hospital Association, 1994:153.
14. Wu AHB, Bowers GN Jr. Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB from BB and macro forms of creatine kinase isoenzymes in patients and healthy individuals. Clin Chem 1982;28: 2017-21.
15. Gardner MJ, Altman DG. Calculating confidence intervals for means and their differences. In: Gardner MJ, Altman DG, eds. Statistics with confidence. London: British Medical Journal, 1989: 20-7.
16. Wu AHB. CK-MB assay methods. A comparison. Lab Manage 1985;23(1):44-50.
17. Wu AHB, Schwartz JG. Update on creatine kinase isoenzyme assays. Diag Clin Test 1989;27(8):16-20.
18. Fisher ML, Plotnick GD. Diagnostic tests for Ml: efficacy and cost containment. Hosp Pract 1984;19(11):195-213.
19. Lewandrowski K, Bailey E, Dhanak E, Laposata M, Flood J. Mandatory laboratory consultation. How one hospital's program reduced overuse of cardiac tests. Lab Med 1994;25:460-3.
20. Saxena S, Anderson DW, Kaufman RL, Hannah JA, Wong ET. Quality assurance study of cardiac isoenzyme utilization in a large teaching hospital. Arch Pathol Lab Med 1995;117:180-3.
21. Anderson FP, Jesse RL, Nicholson CS, Miller WG. The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction. In: Bowie LJ, ed. Assessing clinical outcomes. Utilizing appropriate laboratory testing to decrease healthcare costs and improve patient outcomes (AACC Leadership Series). Washington, DC: AACC, 1996:20-4.